Atika Capital Management LLC Kymera Therapeutics, Inc. Transaction History
Atika Capital Management LLC
- $678 Million
- Q4 2024
A detailed history of Atika Capital Management LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Atika Capital Management LLC holds 136,500 shares of KYMR stock, worth $4.34 Million. This represents 0.81% of its overall portfolio holdings.
Number of Shares
136,500
Previous 97,000
40.72%
Holding current value
$4.34 Million
Previous $4.59 Million
19.6%
% of portfolio
0.81%
Previous 0.53%
Shares
4 transactions
Others Institutions Holding KYMR
# of Institutions
185Shares Held
60.3MCall Options Held
49.6KPut Options Held
17K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$219 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$191 Million2.67% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$164 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$164 Million3.02% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$156 Million32.49% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.74B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...